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INTRODUCTION 
Nanoparticles are sub-nanosized colloidal structures 
ranging from 10 nm to 1000 nm and are compared of 
synthetic or semi synthetic polymers1. The first reported 
nanoparticles were based on non-polymeric systems 
(polymethyl methacrylate, poly acrylide, polystyrene etc.). 
Because of the possibility of chronic toxicity due to tissue 
and immunological response towards non-degradable 
polymeric burden, these were not used systematically. 
Natural polymers i.e., proteins and polysaccharides are 
refused to be used in this area since they vary in purity and 
often require cross-linking that could denature the 
embedded drug. Soon the biodegradable polymers were 
taken up and nanoparticles based on poly (cyano acrylate) 
are extensively used systematically. 
Nanoparticles have been actively explored at delivery 
system for small drug molecules as well as 
macromolecules such as nucleic acids, peptides, proteins 
and hormones. Because macromolecules, such as peptides 
and proteins have stability problems, their encapsulation 
provides protection against gastrointestinal enzymes and 
pH effects, when administered by oral route. Further it was 
realized that the nanoparticles loaded bioactive could not 
deliver drugs at specific organs within the body but 
delivery in addition could also be controlled2. Now a days, 
nanoparticles are widely utilized as a delivery system for 
drug molecules posing problems of solubility, poor 
bioavailability on oral administration and have been 
known to be an efficient approach to achieve better 
pharmacokinetics profiles, reduced toxicity and to increase 
the oral bioavailability of several drugs through   
specialized uptake mechanisms from gastrointestinal tract 
(GIT) through payer’s patches via M cells of lymphatic 
system3. In addition, nanoparticles have also been used in 
vivo to protect the drug entity in the systematic circulation, 
restrict access of the drug to the chosen sites and to deliver 
the drug at a controlled and sustained rate to the site of 
action. Various polymers have been used in the 
formulation of nanoparticles for drug delivery research to 
increase therapeutic benefit, while minimizing side 
effects4. Nanoparticles offer better advantages over other 
carrier systems. A major advantage of nanoparticles which 
makes them an efficient delivery system is their submicron 
size which makes extravasations possible and occlusion of 
terminal blood vessels5. In addition, high density of 
therapeutic agent can often be encapsulated, dispersed or 
dissolved in these nanoparticles, which in turn depends on 
the preparation process to yield different properties and 
release characteristics of the entrapped agent. Though 
liposomes have been used as potential carriers with 
properties including protecting drugs from degradation, 
targeting to site of action and reduction in toxicity or side 
effect. Despite of this versatility, some technical 
limitations including poor reproducibility and stability 
have been reported6. Moreover drug delivery systems 
designed as liposomes cannot be used for controlled 
release of drug because of leakage of drug entrapped inside 
liposomes. On the other hand, polymeric nanoparticles 
offer some specific advantages of increasing the stability 
of drugs/proteins and possess useful controlled release 
properties7. Other features of nanoparticles include low 
number of excipients used in their formulations, simple 
procedure for preparation, high physical stability, and the 
possibility of sustained drug release that may be suitable in 
the treatment of chronic diseases. By varying the polymer 
composition of the particle and morphology, one can 
effectively tune in a variety of controlled release 
characteristics, allowing moderate constant doses over 
prolonged periods of time. Liversidge and Cundy reported 
that availability of drug molecule entrapped in nanoparticle 
was 77% higher than a similar formulation consisting of 
microspheres8. Further, the nanoparticle system was used 
for various routes for administration including oral, nasal, 
parenteral, ophthalmic application9. Oral delivery of small 
drugs molecules can also be achieved which otherwise 
would not be available as injectable such as anticancer 
agents10. Also, the nanoparticles are good candidates to be 
shown as adjuvant for vaccines and advantageous features 
of nanoparticles include increased interaction of drug 
molecules with epithelial cells can be achieved leading to 
maximal absorption of the drug molecule11. 
ADVANTAGES OF NANOPARTICLES 
• Nanoparticles have dimensions below the critical 
wavelength of light renders them transparent, a 
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property which makes them very useful for 
applications in packagings, cosmetics and coatings. 
• Particle size and surface characteristics of 
nanoparticles can be easily manipulated to achieve 
both active and passive targeting. 
• Release of the drug can be controlled or sustained so 
as to achieve increase in therapeutic efficacy of drug 
and reduction in side-effects. 
• They are capable of being stored for a period of upto 1 
year and hence have longer shelf stability. 
• They have the ability to incorporate both hydrophilic 
and hydrophobic drug molecules. 
• They have higher carrier capacity and drugs can be 
incorporated without any chemical reaction and hence 
preserving the drug activity. 
• The system can be administered via different routes 
including oral, nasal, parenteral etc. 
• These have the potential to increase the bioavailability 
of drugs. 
• They have longer clearance time. 
• Site-specific targeting can be achieved by attaching 
targeting ligands to surface of particles or by using 
magnetic guidance. 
DISADVANTAGES OF NANOPARTICLES 
• It involves higher manufacturing costs which may in 
turn lead to increase in the cost of      formulation. 
• These have low encapsulation efficiency. 
• Water-soluble drugs can be rapidly leaked out in the 
presence of blood components. 
• Their small size and large surface area can lead to 
particle-particle aggregation, making physical 
handling of nanoparticles difficult in dry and liquid 
forms. 
• They may trigger immune response and allergic 
reaction. 
• It may involves use of harsh toxic solvents in the 
preparation process. 
IDEAL PROPERTIES OF NANO PARTICLES 
Nanoparticles can be considered as a realizable method for 
drug delivery, following ideal properties of the system are 
required: 
• Stable in blood 
• Non toxic 
• Non thrombogenic 
• Non immunogenic 
• Non inflammatory 
• No activation of  neutrophils 
• Biodegradable 
• Avoidance of the reticulo-endothelial system 
• Applicable to various molecules, such as small 
molecules, proteins, peptides or nucleic acids (platform 
technology) 
• Scalable and inexpensive manufacturing process 
Because poly (butyl-cyano-acrylate) nanoparticles above 
properties and were reported to be useful tools to deliver 
the drugs in several experiments. In addition, they exhibit 
very low toxicity and are considered to be ideal. 
STRUCTURE OF NANOPARTICLES 
Drug nanoparticles consist of the drug and biocompatible 
polymer, either biodegradable or non biodegradable. 
Nanoparticles can be further classified into nanocapsules 
and nanospheres based on their structure. A nanocapsule 
consists of central oily core containing the lipophillic drug 
surrounded by a shell composed of polymer. Nanospheres 
are solid core spherical particulates having a matrix 
consisting of a homogeneous distribution of the drug and 
polymer. The drug is either solubilized in the polymer 
matrix to form an amorphous particle or embedded in the 
polymer matrix as crystallites12. 
 A matrix –type nanoparticles, where the drug 
molecules are dispersed in the polymer matrix. 
 A core shell nanoparticles, where e core containing 
the drug is covered with a polymer shell. 
 A matrix-type nanoparticle, where drug crystals are 
embedded in a polymer matrix. 
SURFACE PROPERTIES OF NANOPARTICLES 
When nanoparticles are administered intravenously, they 
are easily recognized by the body immune systems and are 
then cleared by phagocytes from the circulation13. Apart 
from the size of nanoparticles; their surface hydrophobicity 
determines the amount of adsorbed blood components, 
mainly proteins (opsonins). This in turn influences the in 
vivo fate of nanoparticles14. Binding of these opsonins onto 
the surface of nanoparticles called opsonization acts as a 
bridge between nanoparticles and phagocytes. The 
association of drug to conventional carriers leads to 
modification of drug biodistribution profile, as it is mainly 
delivered to mononuclear phagocytes system (MPS) such 
as liver, spleen, lungs and bone marrow. Indeed, once in 
the blood stream, surface non modified nanoparticles 
(conventional nanoparticles) are rapidly opsonized and 
massively cleared by the macrophages of MPS rich 
organs15. Usually, C3 components of IgG are used for 
recognition of foreign macromolecules. Hence to increase 
the likelihood of the success in drug targeting by 
nanoparticles, it is necessary to minimize the opsonization 
and to prolong the circulation of nanoparticles in vivo. 
This can be achieved by (a) surface coating of  
nanoparticles with hydrophilic polymers/surfactants; (b) 
formulation of nanoparticles with biodegradable 
copolymers with  hydrophilic segments such as 
polyethylene glycol (PEG), polyethylene oxide, 
poloxamer, poloxamine and polysorbate 8016. The zeta (ζ) 
potential of nanoparticles is commonly used to 
characterize the surface charge property of nanoparticles. 
Nanoparticles with a ζ potential above (+/-) 30 mV are 
stable in suspension as the surface charge prevents the 
aggregation of the particles. The ζ potential can also be 
used to determine whether a charged active material is 
encapsulated within the center of the nanoparticles or 
adsorbed onto the surface17. 
METHODS OF PREPARATION OF 
NANOPARTICLES 
Current methods used in preparation of drug nanoparticles 
can be divided into two groups, namely, those based on 
polymerization and those taking advantage of preformed 
polymers. The choice of the method for the preparation of 
nanoparticulate formulation depends upon various factors 
including (a) size of nanoparticles required; (b)  inherent 
properties of drug, e.g., aqueous solubility and  stability;(c) 
surface characteristics such as charge and permeability (d) 
degree of biodegradability, biocompatibility and toxicity 
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(e) drug release profile desired (f) Antigenicity of the final 
product18. 
Emulsion/ Evaporation
19
: This method can be used for 
preparation of particles with sizes varying from a few 
nanometers to micrometers by controlling the stirring rates 
and conditions, showing high efficiency in incorporation 
of lipophillic drugs. Organic solution of polymer and drug 
is emulsified in an aqueous solution containing stabilizer. 
Droplet size is reduced by using a high energy source 
followed by evaporation of organic phase under reduced 
pressure or vacuum to produce fine aqueous dispersion of 
nanoparticles and freeze dried for storage. 
Double Emulsion
20
: This method referred to as variant of 
the Emulsion/Evaporation method as this method suffers 
from poor entrapment efficiency of hydrophilic drugs. 
Therefore, this method is used for incorporating 
hydrophilic drugs. Nanoparticles are recovered by 
ultracentrifugation and lyophilized. High encapsulation 
efficiency can be achieved by this method and considered 
as one of the appropriate methods for proteinateous 
substances due to high solubility of protein in water. Poly 
(lactide-co-glycolide) (PLGA) nanoparticles loaded with 
bovine serum albumin (BSA) were prepared by double 
emulsification method. Typically BSA and PLGA were 
dissolved separately in aqueous and organic phases 
respectively and subjected to ultrasonication to yield water 
in oil emulsion (W1/O). This water in oil was further 
added to a poly vinyl alcohol (PVA) aqueous solution to 
yield was evaporated during stirring first at atmospheric 
pressure and then at reduced pressure (from 100mmHg to 
30mm Hg) to yield nanoparticles. 
Salting Out
21
: This technique is suitable for drugs and 
polymers that are soluble in polar solvents, such as acetone 
or ethanol. Solution of polymer and drug in a slightly 
water miscible solvent is added to aqueous solution 
containing a salting out agent and stabilizer under stirring. 
A small amount of water is added to o/w emulsion for 
dilution which forces diffusion of organic solvent into a 
aqueous phase producing particles in nano size range. This 
process differs from Nano precipitation technique. In it, 
the organic phase is completely miscible in external 
aqueous phase but in case of salting out technique, the 
miscibility of bith the phases is prevented by saturation of 
external aqueous phase with PVA. 
Emulsification – Diffusion22: It is a modified version of 
solvent evaporation method. In this method, the water 
miscible solvent along with a small amount of water 
immiscible organic solvent is used as an oil phase. Due to 
the spontaneous diffusion of solvents an interfacial 
turbulence is created between the two phases leading to 
formation of small particles. As the conc. of water miscible 
solvent increases, a decrease in size of particle can be 
achieved. 
Both solvent evaporation and diffusion method can be 
used for hydrophobic and hydrophilic drugs. In case of 
hydrophilic drug, a multiple w/o/w emulsion needs to be 
formed with the drug dissolved in internal aqueous phase. 
Although this method is a modification of salting out 
procedure, it provides an advantage of avoiding the use of 
salts, thus eliminates for intensive purification steps. 
Limitation of this method is that it suffers from low 
entrapment efficiency of hydrophilic drug in nanoparticles, 
which can be overcome by incorporation of medium chain 
glycerides into aqueous solution which has been found to 
increase the efficiency of water soluble drugs into nano 
spheres offering the advantage of simplicity, narrow 
particle size distribution and ready dispersibility of 
resultant particles. 
Solvent Displacement/ Nanoprecipitation
23
: This method 
incorporates the solution of polymer, drug and lipophillic 
surfactant in a semi polar water miscible solvent and then 
poured into solution containing stabilizer under stirring. 
Rapid diffusion of solvent results in nanoparticles 
formation. Hydrophilic drugs possess low drug loading 
efficiency than hydrophobic drugs because of their poor 
interaction with polymer leading to diffusion of drug from 
polymer in organic phase to the external aqueous 
environment. Barichello et al demonstrated improved 
bioavailability of proteins and peptides using PLGA 
nanoparticles by the nano precipitation method. Jaing et al 
established precipitation method for formation of 
ibuprofen (IBU) nanoparticles stabilized by DEAE dextran 
(Ddex). The process fabricated core shell particles by  
which poor water soluble drugs can be dispersed 
effectively with rather  good  stability during storage. The 
method includes precipitation of IBU in a super saturated 
solution and deposition of Ddex onto the precipitated IBU 
particles through electrostatic interaction. The difficulty 
faced in this preparation method is the choice of 
drug/polymer/solvent/non solvent system in which the 
nanoparticles would be formed and the drug efficiently 
entrapped. 
Emulsion-Difussion-Evaporation: This method 
incorporates both evaporation and diffusion process in 
nanoparticles formation. Solution of polymer in solvent is 
added to aqueous phase under stirring .To this emulsion, 
water is added which results in nano precipitation. The 
basic methodology involves dispersion of organic phase as 
globules in equilibrium with external aqueous phase due to 
continuous stirring. The emulsion is stabilized by 
adsorption of stabilizer at the interface. The globule size is 
further lowered by homogenization. Addition of water 
destabilizes the equilibrium and diffusion of organic 
solvent to aqueous phase causes local super-saturation near 
the interface resulting in nanoparticles formation. The 
organic phase is removed from the preparation by 
evaporation at 400C. 
Coacervation or Ionic Gelation Method
24
: Much 
research is now focused on the nanoparticles using 
biodegradable hydrophilic polymers such as chitosan, 
gelatin and sodium alginate. Calvo and co-workers 
proposed a method for preparation hydrophilic chitosan 
nanoparticles by ionic gelation. The method involves a 
mixture of two aqueous phases; of which is the polymer 
chitosan, a di-block co-polymer ethylene oxide or 
propylene oxide (PEO-PPO) and the other is a poly anion 
sodium tri-polyphosphate. In this method, positively 
charged amino group of chitosan interacts with negative 
charged Tripolyphosphate to form coacervates with a size 
in the range on nanometer. Coacervates are due to the 
result of electrostatic interaction two aqueous phases, 
whereas, ionic gelation involves the material undergoing 
from lipid to gel due to ionic interaction conditions at 
temperature room. 
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Spray Drying
25
: Spray-drying has been widely used for 
the production of micron-sized particles. Spray-dry 
involves the conversion of a solution droplet into a dry 
particle by evaporation of the solvent in a one-step 
process. Temperature –liable compounds such as proteins 
and enzymes have been successfully spray-dried. It has 
been shown that particles consisting of various polymers 
and drugs, both water –soluble and water-insoluble, can be 
prepared without problem of drug leakage to another phase 
and thus, the recovery of drug in the particles is almost the 
particle properties, especially morphology, can be 
controlled by the solvent properties and the spray-drying 
variables. 
NANO PARTICLE CHARACTERIZAION 
TECHNIQUES 
Particle Size Determination
26
: Particle size and size 
distribution are the most important characteristics of 
nanoparticle systems. They determine the in vivo 
distribution, biological fate, toxicity and the targeting 
ability of nanoparticle systems. In addition, they can also 
influence the drug loading, drug release and stability of 
nanoparticles. Many studies have demonstrated that 
nanoparticles of sub-micron size have a number of 
advantages over microparticles as a drug delivery system. 
Static Light Scattering
27
: Dynamic light scattering (DLS) 
is the name that covers different techniques for 
measurement of particle size from the dynamic changes of 
the scattered light intensity. Photon correlation 
spectroscopy (PCS) is at present the most widely used 
name. It relates to the correlation technique that is most 
frequently applied in instruments. Quasi-elastic light 
scattering (QELS) was used as a name often in the past. 
This term relates to the type of interaction between 
particles and light. It is a rapid method for determining the 
mean size, the size distribution and the polydispersity 
index (PdI) of a sample. In the DLS technique, the 
intensity of the scattered light by an ensemble of particles 
is measured at a given angle (90º) as a function of time. 
The Brownian motion of the dispersed particles determines 
the rate of change of the scattered light intensity. The 
temporal intensity changes are converted to a mean 
translational diffusion coefficient. Fast intensity changes 
are related to a rapid decay of the correlation function and 
a large diffusion coefficient. The diffusion coefficient is 
then converted into particle size by means of the Stokes–
Einstein equation. DLS measurement range is about 
0.005–1 and time required for measurement is typically 
about 0.5–10 min. For measurement of large particles 
(larger than about 0.5 μm), three problems are generally 
encountered are: 
 Particles may settle out of the measurement zone to the 
bottom of the cell and thus will gradually become out 
of reach for measurement. 
 Few particles suffice to reach the maximum allowable 
concentration in view of multiple scattering and thus 
changes of their number concentration will bias the 
sizing result. 
 Brownian motion is very slow, especially in liquids of 
increased viscosity. Thus, long measurement times 
have to be applied, during which both instrument and 
suspension should remain stable. Typically, the 
particulate concentration during measurement is around 
10-2 –10-3 % (v/v). 
Scanning Electron Microscopy (SEM)
 28: The scanning 
electron microscope (SEM) is a type of electron 
microscope that images the sample surface by scanning it 
with a high-energy beam of electrons in a raster scan 
pattern. The electrons interact with the atoms that make up 
the sample producing signals that contain information 
about the sample's surface topography, composition and 
other properties such as electrical conductivity. The types 
of signals produced by an SEM include secondary 
electrons, back-scattered electrons (BSE), characteristic X-
rays, light (cathodoluminescence), specimen current and 
transmitted electrons. Secondary electron detectors are 
common in all SEMs, but it is rare that a single machine 
would have detectors for all possible signals. The signals 
result from interactions of the electron beam with atoms at 
or near the surface of the sample. In the most common or 
standard detection mode, secondary electron imaging or 
SEI, the SEM can produce very high-resolution images of 
a sample surface, revealing details about less than 1 to 5 
nm in size. Due to the very narrow electron beam, SEM 
micrographs have a large depth of field yielding a 
characteristic three-dimensional appearance useful for 
understanding the surface structure of a sample. This is 
exemplified by the micrograph of pollen shown to the 
right. A wide range of magnifications is possible, from 
about 10 times (about equivalent to that of a powerful 
hand-lens) to more than 500,000 times, about 250 times 
the magnification limit of the best light microscopes. For 
the same reason, BSE imaging can image colloidal gold 
immuno-labels of 5 or 10 nm diameter which would 
otherwise be difficult or impossible to detect in secondary 
electron images in biological specimens. Characteristic X-
rays are emitted when the electron beam removes an inner 
shell electron from the sample, causing a higher energy 
electron to fill the shell and release energy. 
Transmission Electron Microscopy (TEM)
 29
: A 
transmission electron microscope is analogous to a slide 
projector, with illumination from an electron beam rather 
than light. When an electron beam is impinged upon a 
sample, a black and white TEM image is formed from the 
passage of some electrons through the sample untouched, 
alongside the combination of interactions between other 
electrons and sample atoms (e.g., inelastic/elastic 
scattering, diffraction). If the undiffracted beam is selected 
to form the image, it is referred to as bright-field imaging; 
in contrast, selection of strongly diffracting regions of the 
sample, which would appear brighter than the transmitted 
beam, is known as dark-field imaging. It should be noted 
that electrons may also be absorbed by molecules 
containing large atoms, or by surface contamination (e.g., 
dust, grease). The absorption of a high density of electrons 
in a specific region will cause a buildup of heat, leading to 
sample destruction and poor image quality. Analogous to 
throwing a baseball of varying speeds through a wall, the 
relative degree of penetration through a particular sample 
is governed by the energy of the electron source. That is, 
higher energy electrons (e.g., 200 keV vs. 100 keV) will be 
more penetrating, allowing for the characterization of 
thicker and/or less transparent samples. In general, 
increasing the thickness of a sample, or decreasing the 
energy (i.e., accelerating voltage) of the electron beam, 
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will induce more scattering events through more effective 
interactions between the electron beam and atoms of the 
sample. This effect will enhance image contrast, since 
there is a larger deviation between the path lengths of 
transmitted and scattered electrons that reach the viewing 
screen. However, this improvement of image quality is 
offset by plentiful inelastic collisions that yield a 
broadened wavelength distribution of the electron beam. 
Since individual electrons will have differing energies, 
they will be brought into focus at different points resulting 
in a blurry image (i.e., decreased resolution). 
Atomic Force Microscopy
30
: In this technique, a probe tip 
with atomic scale sharpness is raftered across a sample to 
produce a topological map based on the forces at play 
between the tip and the surface. The probe can be dragged 
across the sample (contact mode), or allowed to hover just 
above (noncontact mode), with the exact nature of the 
particular force employed serving to distinguish among the 
sub techniques. That ultrahigh resolution is obtainable with 
this approach, which along with the ability to map a 
sample according to properties in addition to size, e.g., 
colloidal attraction or resistance to deformation, makes 
AFM a valuable tool. However, size and shape has been 
the most common application to date. The need to raster 
the probe renders the method very time-consuming and the 
size of the sample actually observed is small. 
Nanoparticles are typically presented as an evaporated 
suspension on smooth silicon or mica surface, though not 
without the possibility of deformation. Application of 
various forms of AFM to nanoparticles characterization 
represents an area of active research. 
X-Ray Diffraction (Power X-ray Diffraction)
 31
: The 
geometric scattering of radiation from crystal planes within 
a solid allow the presence or absence of the former to be 
determined thus permitting the degree of crys`
 tallinity to be assessed. In one example; the 
crystallization of interior lipids could be tracked. 
Application of the method is little different from that for 
bulk powders, though broadening of the diffraction 
pattern’s peaks is observed for particles less than 100nm in 
diameter. For nanoparticles, order on the smaller scale can 
be investigated by reducing the wavelength and angle of 
incident radiation. Using electron or neutron beams allows 
reduction of the former parameter due to the shorter De-
Broglie wavelengths of such particles. 
Nuclear Magnetic Resonance Spectroscopy
32
: Nuclear 
magnetic resonance (NMR) can be used to determine both 
the size and the qualitative nature of nanoparticles. The 
selectivity afforded by chemical shift complements the 
sensitivity to molecular mobility to provide information on 
the physicochemical status of components within the 
nanoparticle. For example; the mobility of Miglyol 812 
within solid lipid nanoparticles confirmed the liquid-like 
nature of the interior, though it was more limited than the 
same oil in an o/w emulsion. Pulsed field gradient methods 
allow diffusivity of the entire particle to be quantified and 
compared to produce 2-D, diffusion ordered plots in which 
colloidal behavior and chemical speciation are leveraged 
simultaneously .In one case, the diffusion coefficient is 
used as a surrogate for size of the nanoparticle with results 
that compare well to separation and DLS, though only 
NMR could simultaneously detect micellar precursors. 
Fourier Transform Infrared Spectroscopy
33
: Fourier 
transform spectroscopy is a measurement technique 
whereby spectra are collected based on measurements of 
the coherence of a radiative source, using time-domain or 
space-domain measurements of the electromagnetic 
radiation or other type of radiation. It can be applied to a 
variety of types of spectroscopy including optical 
spectroscopy, infrared spectroscopy (FT-IR, FT-NIRS), 
Fourier transform (FT) nuclear magnetic resonance, mass 
spectrometry and electron spin resonance spectroscopy. 
There are several methods for measuring the temporal 
coherence of the light, including the continuous wave 
Michelson or Fourier transform spectrometer and the 
pulsed Fourier transform spectrograph (which is more 
sensitive and has a much shorter sampling time than 
conventional spectroscopic techniques, but is only 
applicable in a laboratory environment). 
Differential Scanning Calorimetry (DSC)
 34
: Another 
method that is a little different from its implementation 
with bulk materials, DSC can be used to determine the 
nature and speciation of crystallinity within nanoparticles 
through the measurement of glass and melting point 
temperatures and their associated enthalpies. A 
complement to X-ray diffraction, this method is regularly 
used to determine the extent to which multiple phases exist 
in the interior or to which the various constituents, 
including the drug, interact. 
Surface Charge/ Surface Properties of Nanoparticles
35
: 
When nanoparticles are administered intravenously, they 
are easily recognized by the body immune systems, and 
are then cleared by phagocytes from the circulation. Apart 
from the size of nanoparticles, their surface hydrophobicity 
determines the amount of adsorbed blood components, 
mainly proteins (opsonins). This in turn influences the in 
vivo fate of nanoparticles. Binding of these opsonins onto 
the surface of nanoparticles called opsonization acts as a 
bridge between nanoparticles and phagocytes. The 
association of a drug to conventional carriers leads to 
modification of the drug biodistribution profile, as it is 
mainly delivered to the mononuclear phagocytes system 
(MPS) such as liver, spleen, lungs and bone marrow. 
Indeed, once in the blood stream, surface non-modified 
nanoparticles (conventional nanoparticles) are rapidly 
opsonized and massively cleared by the macrophages of 
MPS rich organs. Generally, it is IgG, compliment C3 
components that are used for recognition of foreign 
substances, especially foreign macromolecules. Hence, to 
increase the likelihood of the success in drug targeting by 
nanoparticles, it is necessary to minimize the opsonization 
and to prolong the circulation of nanoparticles in vivo. This 
can be achieved by (a) surface coating of nanoparticles 
with hydrophilic polymers/surfactants; (b) formulation of 
nanoparticles with biodegradable copolymers with 
hydrophilic segments such as polyethylene glycol (PEG), 
polyethylene oxide, poloxamer, poloxamine and 
polysorbate 80 (Tween 80). Studies show that PEG 
conformation at the nanoparticles surface is of utmost 
importance for the opsonins repelling function of the PEG 
layer. PEG surfaces in brush-like and intermediate 
configurations reduced phagocytosis and complement 
activation whereas PEG surfaces in mushroom-like 
configuration were potent complement activators and 
favored phagocytosis. 
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Zeta Potential
36
: Zeta potential is used as a surrogate for 
surface change, and is often measured by observing the 
oscillations in signal that result from light scattered by 
particles located in an electric field, though there are other 
approaches. There are a number of instrumental 
configurations by which this is achieved, mostly using a 
Doppler shift, and the user should familiarize them with 
the particular approach implemented in their equipment. 
Instrumentation concerns aside, the need for dilution begs 
the question of what is an appropriate diluent, because its 
choice can profoundly influence the surface chemistry and 
thus the results. One approach is to use a particle-free 
supernatant to dilute the sample. This will not account for 
concentration effects, however, and obtaining such a 
diluent is nontrivial as the particle size drops. Electro 
acoustic methods should in principal eliminate or reduce 
the need for dilution and its inevitable consequences. 
Nonpolar media and the combination of low mobility with 
high ionic strength are also problematic; however, phase 
analysis light scattering, a newer method in which a phase 
delay shift rather than a frequency shift is observed, 
addresses these issues. 
Electrophoresis
37
: The body’s response to the 
introduction of nanoparticles into circulation is such that 
within a short period of time their surface is festooned with 
lipoproteins and related species. This process will 
determine the clearance and biodistribution of the colloid, 
so evaluating the exact nature of the surface coverage is 
required to achieve a useful understanding. The small size 
of nanoparticles allows their electrophoretic behavior to be 
observed using bio-analytical tools such as iso-electric 
focusing and 2-D poly acryl-amide gel electrophoresis. As 
with any ex vivo approach, the investigator needs to take 
into account the effect that sample preparation may have 
on the experimental observations. Similar information has 
been derived by electrophoresis of serum proteins 
desorbed from incubated nanoparticles. 
DRUG LOADING AND IN-VITRO RELEASE 
PROFILE OF NANOPARTICLES 
Lipophilic or poorly soluble drugs are often incorporated 
in a nanocapsule or nanoparticles using hydrophobic 
polymers. The selection of organic solvent which is to 
used in reservoir of system depends on the solubility of the 
drug. Depending on the drug hydrophobicity, it may 
require highly non-polar solvents like chloroform 
andmethylene chloride. The release of incorporated drug 
depends on partitioning behaviour 
between capsularreservoir and dispersion phase sink. 
In hydrophilic drugs, the aqueous phase contains the drug 
molecules which are embedded in the polymeric cross-
linked matrix. Drug-polymer affinity and interaction may 
be the critical factors that determine and regulate drug 
payload or percent drug incorporation and drug release. 
The encapsulation of drug in hydrophilic polymers 
requires some appropriate organic solvent depending on 
the procedural and formulation factors. 
In-vitro release profile of lipophilic drugs: Inner 
structure of polymeric colloidal system largely affects the 
in-vitro release behaviour of lipophilic compounds. Drug 
release from nanocapsules mainly occurs by the drug 
partition from the colloidal suspension to the external sink 
solution and thus in turn depends on the solubility of the 
drug in the oily core and external receptor medium. On the 
other hand, the in-vitro release characteristics of the 
lipophilic compounds from the nanoparticles are 
dominated by the polymer erosion and in most of the cases 
a biphasic release pattern results. The first phase (burst 
release) is due to the release of the drug adsorbed on the 
particles surface and the second phase is due to drug 
diffusion out of the polymer matrix. 
In-vitro release profile of hydrophilic drugs: A 
hydrophilic compound can be adsorbed on to preformed 
nanospheres or entrapped within a polymer matrix 
composed of natural macromolecules or synthetic 
polymers. Generally, in the first case, the release of 
hydrophilic drugs from polymeric nanoparticles occurs 
relatively fast (1-2 days) and the release rate reflects the 
affinity of the drug for the polymer. In the second case 
however, the polymer degradation rate and inner structure 
of nanoparticle in combination may influence the drug 
release profile. 
THERAPEUTIC APPLICATIONS OF 
NANOPARTICLES 
Nanoparticles have been widely employed for different 
therapeutic applications, some of which are listed below: 
 For intracellular targeting of anti-effective drugs to 
combat the difficult to treat’ intracellular infections of 
the human body. 
 For targeting of cytostatic drugs to reduce toxicity and 
increase therapeutic activity. 
 For specific targeting of anti-inflammatory drugs to 
areas of inflammation, by which the side-effects of 
these drugs can be minimized. 
 For ocular delivery systems, to deliver pilocarpine and 
other miotic drugs. 
 As carriers for radionucleotides for diagnostic 
purposes in nuclear medicines. 
 To improve the solubility and bioavailability of poorly 
soluble drugs and protects from gastrointestinal 
enzymes and hence, helps in peroral absorption. 
 For skin and hair care in the form of solid 
nanoparticles, wherein the oily core contains a wide 
variety of different cosmetic oils and lipophilic agents. 
 To deliver drugs across the blood brain barrier (BBB). 
 To formulate sustained release preparations. 
 For the controlled delivery of disinfectants or algicide 
into large bodies of water such as insect pest feed . 
 For targeted delivery of proteins and peptides. 
 As adjuvants to render antigens potent enough to be 
useful for vaccines. 
 Have prolonged systemic drug effect due to prolonged 
systemic circulation and hence, uptake by 
reticuloendothelial system can be avoided. 
 
CONCLUSION 
Nanoparticles are the colloidal particles whose size ranges 
in the nanometric size which are mainly employed through 
parenteral route, hence, requiring careful development of 
test methods and acceptance criteria for the specifications. 
The foregoing shows that nanoparticulate systems have 
great potentials, being able to convert poorly soluble, 
poorly absorbed and labile biologically active substance 
into promising deliverable drugs.To optimize this drug 
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delivery system, greater understanding of the different 
mechanisms of biological interactions, and particle 
engineering, is still required. Further advances are needed 
in order to turn the concept of nanoparticletechnology into 
a realistic practical application as the next generation of 
drug delivery system. In particular, the in vitro release test 
method and acceptance criteria require rigorous scientific 
consideration and should be developed with an eye toward 
understanding the mechanisms of drug release. The final 
specifications need to ensure the safety, identity, strength, 
performance, and quality of the drug product at release and 
during storage through the end of its shelf-life. The 
objective of nanoparticulate system is to achieve a desired 
pharmacological response in a sustained manner at a 
selected site without undesirable interactions at the other 
sites. This is especially important in cancer chemotherapy, 
enzyme replacement therapy etc.  
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